Subhashis Mitra
Michigan State University
18 Papers
47 Citations
Subhashis Mitra is an academic researcher from Michigan State University. The author has contributed to research in topics: Medicine & Oritavancin. The author has an hindex of 8, co-authored 16 publications. Previous affiliations of Subhashis Mitra include Wayne State University & Marshfield Clinic.
Chat about Author
Papers
Swallow Syncope: A Case Report and Review of the Literature
TL;DR: A woman, aged 60 years, presented with an episode of a syncopal attack associated with swallowing a sandwich, which resolved after permanent pacemaker placement.
46
Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill Patients.
Gary E. Stein,Curtis L. Smith,Amy Scharmen,James M Kidd,Christopher C Cooper,Joseph L. Kuti,Subhashis Mitra,David P. Nicolau,Daniel H. Havlichek +8 more
TL;DR: The study results suggest that the current dosing regimens of CZA can provide effective antimicrobial activity in ICU patients against CZA-susceptible (MIC ≤8 mg/L) isolates against multi-drug-resistant Enterobacteriaceae susceptible to CZA.
44
Gastric antral vascular ectasia: case report and review of the literature.
TL;DR: The clinical, endoscopic, histologic, and therapeutic aspects of this entity are described and two cases of gastric antral vascular ectasia with two strikingly different endoscopic appearances are reported.
Immunogenicity of 13-Valent Conjugate Pneumococcal Vaccine in Patients 50 Years and Older with End-Stage Renal Disease and on Dialysis.
TL;DR: Vaccination with PCV13 induces antibody responses to vaccine serotypes in patients with end-stage renal disease and on dialysis at 2 months postvaccination, however, the decline in antibody concentrations at 12 months post vaccination with a conjugate pneumococcal vaccine requires further study.
32
Targeting Cytomegalovirus-Infected Cells Using T Cells Armed with Anti-CD3 × Anti-CMV Bispecific Antibody
Lawrence G. Lum,Mayur Ramesh,Archana Thakur,Subhashis Mitra,Abhinav Deol,Joseph P. Uberti,Philip E. Pellett +6 more
TL;DR: This nonmajor histocompatibility complex restricted strategy for targeting CMV could be used to prevent or treat CMV infections after allogeneic stem cell transplantation or organ transplantation.
20